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Reply
I would like to thank the authors of the “Letter to the Editor”
of reading and critiquing our article. I have responded to each
comment below.
1. Although the study employs patient randomization and indepen-
dent observers, a robust methodology is paramount where a
commercially sponsored therapy cannot be blinded to its partici-
pants. Themethodology states that underlying arterial and venous
insufficiencywas dealt with prior to study inclusion.However, one
of the three subgroups, “combined ulcers,” contains limbs with
ABPI values of 0.6 to0.85. Further, due to insufficient patients, no
statistical analysis of sub-group data is performed.
Despite the commercially sponsored therapy (ie, only ma-
terial support to the VAC group), the methodology such as
central randomization, multi-center approach, and indepen-
dent observers were blinded sufficiently to the data collection.
Before randomization, only these ulcers were included in the
study that remained recalcitrant despite solving underlying
pathology or therapy was not possible because of illness,
age, . . . . Although the same tendency was seen during the
sub-group analysis, none of this data was included due to the
insufficient patients.
2. Body mass index and lower limb edema are associated with leg
ulceration and may influence wound exudate. This data, which is
not presented, would be of particular importance in the arteriolo-
sclerotic group with no underlying arterial or venous disease.
The clinic of Martorell’s ulcers (arteriolosclerotic ulcers) is
rather characteristic. The first symptom consistently reported in
literature is a painful red blister, which soon becomes blue,
purpuric (erythrocyanotic spot), and finally ulcerates. Beside
this, ulcerations often are preceded by characteristic pigmented
pretibial patches (PPPs), also called “shin spots”. These light-
to-more-darker pigmented, nummular maculae arise spontane-
ously. They are often localized at the anterior or medial part of
the lower leg. The PPPs may be bilateral and do not need to
ulcerate on the other leg at the same time. The PPPs are
reported in 50% of hypertensive patients, but may be distin-
guished either clinically, or by histological examination from
the lesions seen in diabetes or benign hypertension.
Martorell’s ulcer is a superficial ulcer with necrotic base and
purple-reddish edges. Irregular episodes of extension of the
ulcer’s edge may occur and satellite lesions may appear. Rest or
elevation does not relieve the extreme painful ulcers. Schnier
showed that disturbed night rest due to pain is seen in 75% of
the patients. The ulcer is classically located on the anterolateral
aspect of the leg at the middle third, but it may be located on
the posterolateral side as well. Bilateral and symmetric locations
are also described. The wound healing is extremely slow and
response to standard treatments usually is poor. Martorell’s
ulcer predominantly occurs in women aged between 50 and 70
years. But several investigators have described this type of leg
ulcer in male patients as well.
Since the original reports, little has been written concerning
the pathogenesis. One of these reasons was that until recently, it
was impossible to study the functional microcirculation of a local-
ized vascular wound bed. Hartling et al. investigated hypertensive
patients with an isotopic clearance method (99mTc) and demon-
strated that an in vivo study of localized vascular beds is possible.
Duncan and Faris described six Martorell’s ulcers in which they
examined themicrocirculationusing themethods ofHartling et al.
The study showed that patients withMartorell’s ulcers have a high
vascular resistance (despite having normal ankle/ brachial pressure
ratios). This increase in resistance suggests a narrowing of arte-
rioles, which not only result in reduced tissue perfusion, but also in
reduced effectiveness of the compensatory mechanism (normally
exists distal to an arterial narrowing or occlusion). In response to
the reduction in the blood pressure that occurs distal to an arterial
narrowing, there normally is an arteriolar dilatation that maintains
tissue perfusion until severe narrowing or occlusion develops.
However, if there is arteriolar disease, as in patients with a history
of hypertension, the arteriolesmay not be able to dilatewhendistal
blood pressure is reduced.When the arteriolar narrowing is severe,
the tissue perfusion may be reduced to a level that results in local
ischemia and ulceration. These findings correlate with the study of
Williams and Took, who used laser Doppler fluxmetry. In litera-
ture, no relationwas describedbetween thewoundhealingprocess
or pathogenesis and the bodymass index or lower limb edema like
the authors of this letter suggested.
The arterial supply of the skin derives from two plexuses:
the cutaneous and subpapillary plexus. The subpapillary plexus
supplies terminal arterioles, which course upwards towards the
epidermis. Should luminal narrowing or occlusion affect a
sufficient number of these vessels, this area will result into an
infarction of the skin.
The increased local vascular resistance and the exaggerated
vasoconstriction response to an increase in venous transmural
pressure may also influence the localization of the ulcer. Whilst
slight local trauma was felt to be significant to the development of
arteriolar lesions and subsequent ulceration, it has been acknowl-
edged that ulcers also develop in absence of a previous trauma
(50% of all Martorell’s ulcers). Other possible causal factors in the
development of Martorell’s ulcers are: changes in the sympathetic
enervation, a persistent arteriolar hypertonia, and abnormal arte-
riolar vasal response on vaso-active substance.Why theMartorell’s
ulcer is located on the outer part of the lower leg is not clear. This
might be due to micro-traumata or imbalance in arterial perfusion
ratio. Likewise it is not clear that these leg ulcers can be located
bilaterally (“mirror phenomenon”).
Histology of theMartorell’s ulcers shows an increase in the
size of the arteriolar wall by hypertrophy of the media muscu-
lature and intimal hyperplasia. Occasionally, hyalinosis of the
media has been found. The hyaline material is composed of
plasma proteins, lipids, and basement membrane material. The
arteriolosclerosis may be absent, particularly in early cases of
hypertension, although in hypertensive patients, these are often
more generalized and diffuse. Peri-arteritis is frequently found,
but should be regarded as part of the diffuse soft tissue inflam-
mation of corium and subcutis adjacent and subjacent to the
skin necrosis. Compared with arteries, venous vessels are more
severely damaged by surrounding inflammation and may de-
velop thrombotic occlusions. Sometimes, there also may be
endarterial proliferation specifically caused by hypertension,
which can be separated from endarteritis because of subendo-
thelial hyalinosis. Also, in the surrounding seemingly normal
skin (on other location, for instance the lower arm) histopatho-
logic changes like endothelial proliferation, hyaline- and fibrin-
oid subendothelial changes, medial hypertrophy. and discrete
periarteriolitis can be seen. But all these changes are not always
present. In contrast to the vessels at the ulcer edge, those in the
ulcer base showed nonspecific changes.
The ratio between the vessel-lumen and wall thickness has
been compared with other causes of chronic ulcerations. In
patients with Martorell’s ulcers, the ratio vessel-lumen/wall
thickness showed to be significantly reduced.
3. The baseline characteristics demonstrate a median ulcer area
in the VAC group of 33 cmD (range 2 to 150), vs control of
43 mD (range 3 to 250). In the statistical analysis of the
determinants of wound healing duration, this difference in
areas is just short of significance at P .058. A control group
JOURNAL OF VASCULAR SURGERY
Volume 46, Number 3 Letters to the Editor 615
population with larger ulcers would require greater re-epi-
thelialization and more skin grafting.
As we already suggested in the article, the existence of
prognostic keys in wound healing, such as the ulcer surface, are
known. Multivariate analysis was performed using Cox’s pro-
portional hazards model to adjust for small imbalances in the
baseline distribution of relevant prognostic factors to wound
healing. Hazard ratios and their 95% confidence intervals (CI)
to the ulcer areas between both groups show indeed a close but
no significant difference.
4. The primary endpoint measurement is time to complete epithe-
lialization, subdivided into two phases; the wound preparation
time following debridement and time to complete healing
following skin application. Critical to the difference in median
healing times (VAC 29 days vs control 45 days) is the delayed
application of skin in the control group (VAC 7 days vs control
17 days). The methodology states that 100% granulation and
minimal exudate was required during wound preparation be-
fore applying skin grafts. The results of the trial are therefore
influenced greatly by the assessment of these two parameters by
two observers. The amount of wound exudate would normally
be estimated by inspection of dressings, not possible in the VAC
group. It is unclear if both observers assessed all wounds,
whether they were independent of each other and, if so, the
degree of concordance.
The assessment of wound fluid is indeed one of the critical
key factors to determine the preparation stage. During the VAC
procedure this assessment is even easier to determine because
the collection canister, hidden in the pump, can be inspected
very easily.
5. Further, we deduce from the results that median healing times
following skin application were similar for both groups (VAC
22 days vs controls 28 days) despite better initial skin graft
survival in the VAC group.
That’s correct. Proves this conclusion the necessity of VAC
even after the transplantation? New studies with cross-over
need to be done to answer this question.
6. Complication rates, including “cutaneous damage,” were
higher in the VAC group vs controls (40% vs 23%), not statis-
tically significant. However, this analysis would be altered if the
two patients in the control group with “bleeding” from donor
sites, complications not related to recipient ulcers, or differ-
ences in therapy, were omitted.
The complication rates between both groups are indeed
not significant. However, the complication “bleeding from the
donor site” is indeed not related to the wound therapy choice
and, therefore, should not be included. Analyzing the compli-
cation rates without the “bleeding from the donor site,” would
show a significant difference caused by the cutaneous damage
due to VAC therapy, whereas drapes to seal the ulcers will
irritate the wound borders.
Hopefully, these answers elucidate all questions and mis-
understandings in our study.
Jeroen D. Vuerstaek, MD
DermaClinic
Genk, Limburg, Belgium
doi:10.1016/j.jvs.2007.04.056
Regarding “Early carotid endarterectomy in
symptomatic patients is associated with poorer
perioperative outcomes”
In their review of outcomes after carotid endarterectomy
(CEA), which included stratification for time from event to sur-
gery, Rockman et al1 observed that “patients who underwent CEA
4 weeks of ipsilateral TIA/stroke experienced a significantly
increased rate of perioperative complications compared with pa-
tients who underwent CEA in a more delayed fashion.” It was,
thereafter, suggested that a waiting period of 4 weeks be recom-
mended in “stroke patients who were candidates for CEA.” This
interpretation was subsequently challenged2 as being contrary to
pooled analyses from the European Carotid Surgery Trial (ECST)
and the North American Symptomatic Carotid Endarterectomy
Trial (NASCET),3 which showed that the benefit from CEA was
maximal in symptomatic patients operated on within 2 weeks of
the index event.
In responding, Rockman4 did seem to concede this that this
criticism might be true (“clearly Richards and colleagues are cor-
rect that our results were markedly different from a number of
studies including the ECST and NASCET”). By contrast, I would
like to suggest that not only are both groups correct in their
interpretation of contemporary data, but that there is an evenmore
important message from the New York series.
The Carotid Endarterectomy Trialists Collaboration (CETC)
combined data from 5893 patients randomized in ECST,
NASCET, and the Veterans Administration (VA) study having
remeasured all prerandomization angiograms using the NASCET
method.3 The Table3,5 details long-term stroke prevention (per
1000 CEAs at 5 years) relative to the delay to surgery. As is clearly
seen, the benefit from CEA does appear maximal in the first 2
weeks, thus not seeming to support Rockman’s conclusion.
However, what both groups have missed is the fact that by
operating early (even with a higher initial risk), one may still be
preventing more strokes in the long term. The Figure includes the
same data used to produce the Table, but now with stratification
for variations in the operative risk.5 Not withstanding the limita-
tions of secondary analyses, this figure suggests that even if a
surgeon were to perform CEA 2 weeks of the index event with a
10% procedural risk, which many would consider unacceptable, it
is still possible that he or she might be preventing more strokes in
the long term than if surgery were deferred for4 weeks and then
performed with no risk!
At a time when “beauty contests”—who can do surgery or
angioplasty with the lowest procedural risk— are beginning to
dominate media reporting, wemust never lose sight of the fact that
although a delay to intervention may produce better outcomes for
the surgeon or interventionist, this may be at the cost of poorer
long-term outcomes for the patient.
Finally, howmany of you JVS readers silently mocked the poor
results from the angioplasty arm of the French EVA-3S trial, while
failing to notice that 40% of treatments were performed 4
weeks of the index event?6 I would, therefore, respectfully suggest
that the 5% procedural risk incurred by the New York group whilst
Benefit conferred by carotid endarterectomy in
symptomatic patients with 50% to 99% stenoses stratified
for “time from event to surgery”*
Delay to CEA
(weeks)
Patients,
n
Strokes prevented/
1000 CEAs at 5 years
2 weeks 1183 185
2-4 weeks 1054 98
4-12 weeks 2312 55
12 weeks 1344 8
CEA, Carotid endarterectomy.
*Based on a reworking of data from the Carotid Endarterectomy Trialists
Collaboration, who combined the European Carotid Surgery Trial (ECST)
and the North American Symptomatic Carotid Endarterectomy Trial
(NASCET), and Veterans Administration databases, having remeasured all
prerandomization angiograms using the NASCET method.3,5
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